비교리스트

 카트 문의
시장보고서
상품코드
1629263

세계의 말초 인터벤션 시장 : 제품 유형별, 시술별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2025-2032년)

Peripheral Interventions Market, By Product Type, By Procedure, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 384 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

말초 인터벤션 시장 규모는 2024년에 96억 7,834만 달러에 달하며, 2025-2032년에 CAGR 9.1%로 확대

말초 중재 시장 역학

혈관 질환의 유병률 증가가 시장 성장을 주도합니다.

혈관 질환의 유병률 증가는 말초 중재시술 시장의 성장을 가속하는 중요한 요인입니다. 말초동맥질환(PAD), 정맥류, 심부정맥혈전증(DVT)을 포함한 혈관질환은 고령화, 좌식 생활습관, 당뇨병, 흡연, 고혈압과 같은 위험요인 증가로 인해 점점 더 흔해지고 있습니다. 세계보건기구(WHO)에 따르면 심혈관계 질환(CVD)은 전 세계 사망 원인 1위로 전체 사망자의 32%%를 차지하는 것으로 추정되며, 그 대부분은 말초혈관 질환에 기인하는 것으로 추정됩니다. 혈관 질환이 확산됨에 따라 효과적이고 덜 침습적인 치료법에 대한 필요성이 증가하고 있습니다. 스텐트, 혈관형성 풍선, 카테터와 같은 말초혈관 중재 장비는 혈류를 개선하고 증상을 완화하며 사지 절단이나 뇌졸중과 같은 심각한 합병증을 예방하는 신속하고 정확한 치료를 가능하게 함으로써 해결책을 제시합니다. 의료 시스템이 혈관 질환 증가에 대응하기 위해 노력함에 따라 이러한 치료법에 대한 수요는 증가할 것으로 예상됩니다. 또한 의료 기술의 발전으로 말초 중재술이 더욱 안전하고 효과적이며 최소 침습적으로 발전하고 있으며, 혈관 질환 치료에 이러한 기기의 채택이 더욱 확대되고 있습니다. 이러한 유병률 증가와 의료 기술 혁신의 결합은 향후 수년간 말초 중재시술 시장의 큰 성장을 가속할 것으로 예상됩니다.

말초 중재 시장 : 주요 고려사항

  • 당사의 리서치 애널리스트들이 공유한 분석에 따르면 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 9.1%%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.
  • 제품 유형별로는 스텐트가 2024년 가장 큰 시장 점유율을 보일 것으로 예상됩니다.
  • 최종 용도별로는 병원이 2024년 주요 기능입니다.
  • 지역별로는 북미가 2024년 매출을 창출하는 주요 시장이 될 것으로 예상됩니다.

말초중재 시장 : 세분화 분석

세계 말초 중재 시장은 제품 유형, 시술, 최종 용도, 지역에 따라 세분화됩니다.

제품은 유형별로 스텐트, 카테터, 카테터, 가이드와이어, 풍선, 혈관폐쇄장비 등 5가지로 분류됩니다. 스텐트는 동맥을 열어 혈류를 회복시키는 효과가 입증되어 시장을 독점하고 있으며, 말초동맥질환(PAD)과 같은 증상에 대한 중요한 솔루션이 되고 있습니다. 또한 약제용출성 스텐트, 생체흡수성 스텐트 등 스텐트 기술의 발전으로 안전성, 성능, 환자 예후가 개선되어 널리 보급될 수 있는 원동력이 되고 있습니다.

시장은 최종 용도별로 병원, 전문 클리닉, 외래수술센터(ASC)의 세 가지로 분류됩니다. 병원은 첨단 의료 인프라, 전문 전기생리학 검사실의 가용성, 복잡하고 대량의 시술을 처리할 수 있는 능력으로 인해 시장을 독점하고 있습니다. 또한 병원은 시술 전후 모니터링을 포함한 종합적인 치료를 제공하므로 말초 중재 치료를 필요로 하는 환자들에게 선호되는 환경입니다.

말초중재 시장 : 지역별 분석

북미가 가장 큰 시장 점유율을 차지하고 있는데, 그 주요 이유는 높은 혈관질환 유병률, 인구 고령화, 첨단 의료 인프라 때문입니다. 특히 미국은 저침습적 치료에 대한 높은 수요와 의료기술의 발전으로 말초중재시술 시장이 잘 형성되어 있습니다.

독일, 영국, 프랑스와 같은 국가들이 혁신적인 말초 중재시술 장비의 도입에 주력하고 있는 유럽은 이 시장에서 중요한 역할을 하고 있습니다. 유럽 시장은 강력한 의료 정책, 혈관 질환에 대한 인식 증가, 첨단 치료에 대한 접근성 확대 등의 혜택을 누리고 있습니다. 반면, 아시아태평양은 중국, 인도, 일본과 같은 국가들의 환자 인구 증가, 의료 시설 개선, 가처분 소득 증가로 인해 빠르게 성장하고 있습니다. 이들 국가에서는 생활습관병의 유병률이 증가함에 따라 비용 효율적이고 덜 침습적인 치료 옵션에 대한 수요가 증가하고 있습니다. 라틴아메리카와 중동 및 아프리카에서는 의료 시스템 개선과 혈관 질환에 대한 인식이 높아짐에 따라 말초 중재시술 시장이 점차 확대되고 있으며, 이는 시장 성장과 기술 혁신의 새로운 기회를 창출하고 있습니다.

말초 중재 시장 : 경쟁 구도

말초신경 중재 시장의 경쟁 환경은 혁신과 신제품 개발에 집중하는 신생 기업과 함께 여러 기존 기업의 존재로 특징지어집니다. 시장 진출기업은 제품 품질, 기술 발전, 전략적 파트너십을 기반으로 경쟁하고 있습니다. 주요 기업은 약제용출성 스텐트, 생체흡수성 스텐트, 첨단 카테터 기술 등 환자 예후를 개선하고 합병증 위험을 줄이기 위한 기능을 갖춘 제품을 지속적으로 개선하고 있습니다. 이러한 혁신은 말초혈관질환 치료에 있으며, 보다 안전하고 효과적이며 오래 지속되는 솔루션을 제공하는 것을 목표로 하고 있습니다. 또한 기업은 M&A 및 의료 기관과의 제휴를 통해 지역적 범위를 확장하고 새로운 환자 집단에 접근하기 위해 시장에서의 입지를 확대하고 있습니다. 또 다른 중요한 전략은 비용 효율적인 솔루션에 중점을 두는 것으로, 특히 신흥 시장에서는 저렴한 가격과 접근성이 채택을 촉진하는 중요한 요소로 작용하고 있습니다. 규제 당국의 승인과 엄격한 안전 기준을 준수하는 것도 이러한 경쟁 환경에서 중요한 차별화 요소이며, 기업은 새로운 제품을 도입하기 위해 복잡한 규제 환경을 헤쳐나가야 합니다. 경쟁의 역학은 기기 성능 향상과 말초 중재술의 적응증 확대에 초점을 맞춘 진행 중인 임상시험, 연구 및 개발 활동으로 인해 더욱 강화되고 있습니다. 특히 혈관 질환의 부담이 증가하고 있는 지역에서는 첨단 저침습적 치료에 대한 수요가 전 세계에서 증가함에 따라 이러한 상황은 계속 진화하고 있습니다.

목차

제1장 말초 인터벤션 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 말초 인터벤션의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 말초 인터벤션 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 지도제작
  • 규제 체제의 분석

제5장 말초 인터벤션 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 말초 인터벤션 시장 구도

  • 말초 인터벤션 시장 점유율 분석(2024년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 말초 인터벤션 시장 : 제품 유형별

  • 개요
    • 부문별 점유율 분석 : 제품 유형별
    • 스텐트
    • 카테터
    • 가이드와이어
    • 풍선
    • 혈관 폐쇄 기기

제8장 말초 인터벤션 시장 : 시술별

  • 개요
    • 부문별 점유율 분석 : 시술별
    • 혈관성형술
    • 스텐트 유치
    • 어테로머 절제술
    • 혈전용해

제9장 말초 인터벤션 시장 : 최종 용도별

  • 개요
    • 부문별 점유율 분석 : 최종 용도별
    • 병원
    • 외래 수술 센터(ASC)
    • 전문 클리닉

제10장 말초 인터벤션 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 말초 인터벤션 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Abbott
    • Boston Scientific
    • Medtronic
    • Cook Medical
    • Cordis
    • Terumo Corporation
    • Johnson &Johnson
    • Teleflex
    • B. Braun Melsungen
    • Penumbra, Inc.
    • Endologix
    • Merit Medical Systems
    • Philips Healthcare
    • AngioDynamics
    • Siemens Healthineers
    • Others

제12장 AnalystView의 전방위적 분석

KSA 25.02.18

REPORT HIGHLIGHT

Peripheral Interventions Market size was valued at US$ 9,678.34 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

Peripheral interventions refer to medical procedures that target the peripheral arteries, veins, or nerves outside the central body organs such as the brain and heart. These interventions typically involve minimally invasive techniques to treat conditions like peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, and other vascular disorders. They can include the use of devices such as stents, angioplasty balloons, catheters, or embolization coils, which are inserted into the body through small incisions or punctures. The need for peripheral intervention devices arises due to the increasing prevalence of lifestyle-related diseases such as diabetes, hypertension, and smoking, which contribute to vascular disorders. These devices help in restoring normal blood flow, alleviating symptoms, and improving the overall quality of life for patients. Peripheral interventions also offer several benefits over traditional open surgeries, including reduced recovery times, fewer complications, and minimal scarring. The importance of peripheral intervention devices lies in their ability to offer non-surgical, effective solutions to patients with vascular issues. By enabling quick intervention and precise treatment, these devices play a critical role in managing chronic conditions, preventing more serious complications like amputations or strokes, and improving patient outcomes in both short-term and long-term healthcare settings.

Peripheral Interventions Market- Market Dynamics

Rising Prevalence of vascular diseases to drive market growth

The rising prevalence of vascular diseases is a significant factor driving the growth of the peripheral interventions market. Vascular diseases, including peripheral artery disease (PAD), varicose veins, and deep vein thrombosis (DVT), are becoming more common due to an aging population, sedentary lifestyles, and an increase in risk factors such as diabetes, smoking, and hypertension. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for an estimated 32% of all deaths, with a significant portion attributed to peripheral vascular disorders. As vascular diseases become more widespread, there is a growing need for effective, minimally invasive treatment options. Peripheral intervention devices, such as stents, angioplasty balloons, and catheters, offer a solution by enabling quick and precise treatment that improves blood flow, alleviates symptoms, and prevents severe complications like limb amputations or strokes. The demand for these interventions is anticipated to rise as healthcare systems aim to address the rising burden of vascular diseases. In addition, advancements in medical technology continue to make peripheral interventions safer, more effective, and less invasive, further boosting the adoption of these devices in the treatment of vascular conditions. This combination of increasing prevalence and medical innovation is expected to drive significant growth in the peripheral interventions market in the coming years.

Peripheral Interventions Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)
  • Based on Product Type segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Hospitals was the leading Function in 2024
  • Based on region, North America was the leading revenue generator in 2024

Peripheral Interventions Market- Segmentation Analysis:

The Global Peripheral Interventions Market is segmented based on Product Type, Procedure, End-Use and Region.

The market is divided into five categories based on Product Type: Stents, Catheters, Guidewires, Balloons, and Vascular Closure Devices. Stents dominate the market due to their proven effectiveness in restoring blood flow by keeping arteries open, making them a critical solution for conditions like peripheral artery disease (PAD). Additionally, advancements in stent technology, such as drug-eluting and bioresorbable stents, have enhanced their safety, performance, and patient outcomes, driving their widespread adoption.

The market is divided into three categories based on End-Use: Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Hospitals dominate the market due to their advanced medical infrastructure, availability of specialized electrophysiology labs, and ability to handle complex and high-volume procedures. Additionally, hospitals provide comprehensive care, including pre-and post-procedure monitoring, making them the preferred setting for patients requiring peripheral intervention treatments.

Peripheral Interventions Market- Geographical Insights

North America holds the largest market share, primarily due to the high prevalence of vascular diseases, the ageing population, and advanced healthcare infrastructure. The U.S., in particular, has a well-established market for peripheral interventions, driven by a high demand for minimally invasive procedures and ongoing advancements in medical technologies.

Europe also plays a crucial role in the market, with countries like Germany, the UK, and France focusing on the adoption of innovative peripheral intervention devices. The European market benefits from strong healthcare policies, increasing awareness of vascular diseases, and expanding access to advanced treatments. In contrast, the Asia Pacific region is experiencing the fastest growth, fueled by a large patient population, improving healthcare facilities, and increasing disposable incomes in countries like China, India, and Japan. As the prevalence of lifestyle-related diseases rises in these nations, there is a growing demand for cost-effective, minimally invasive treatment options. In Latin America and the Middle East & Africa, the peripheral interventions market is gradually expanding, as healthcare systems improve and awareness of vascular conditions increases, creating new opportunities for market growth and innovation in these regions.

Peripheral Interventions Market- Competitive Landscape:

The competitive landscape of the peripheral interventions market is characterized by the presence of several established players, alongside emerging companies focusing on innovation and new product development. Market participants compete based on product quality, technological advancements, and strategic partnerships. Leading companies are continually working to enhance their product offerings with features such as drug-eluting stents, bioresorbable stents, and advanced catheter technologies to improve patient outcomes and reduce the risk of complications. These innovations aim to provide safer, more effective, and longer-lasting solutions for treating peripheral vascular diseases. Additionally, companies are expanding their market presence through mergers, acquisitions, and collaborations with healthcare institutions to increase their geographical reach and access new patient populations. Another key strategy is the emphasis on cost-effective solutions, particularly in emerging markets, where affordability and accessibility are critical factors in driving adoption. Regulatory approvals and compliance with stringent safety standards are also key differentiators in this competitive landscape, as companies must navigate complex regulatory environments to introduce new products. The competitive dynamics are further shaped by ongoing clinical trials, research, and development activities, which focus on enhancing device performance and expanding the indications for peripheral interventions. This landscape continues to evolve as the demand for advanced, minimally invasive treatments rises globally, particularly in regions with a growing burden of vascular diseases.

Recent Developments:

  • In April 2024, Abbott's breakthrough dissolving stent, the Esprit BTK System, received FDA approval for treating arteries below the knee, offering a new, effective solution for patients with chronic limb-threatening ischemia (CLTI) and peripheral artery disease (PAD). This innovative device, which dissolves over time, outperforms traditional balloon angioplasty in improving outcomes and reducing disease progression.
  • In June 2024, Philips launched the Duo Venous Stent System, a groundbreaking medical device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). This device, which received premarket approval from the FDA, addresses challenges in venous anatomy by combining two stents, Duo Hybrid and Duo Extend, offering a differential design to accommodate vessel curvature and minimize stent complications. The system is part of Philips' broader strategy to enhance CVI treatment through innovative vascular technologies.
  • In November 2024, Solaris Endovascular, a new vascular stent graft company, was launched in the United States. The company is introducing innovative technologies aimed at improving patient outcomes in the treatment of peripheral artery disease (PAD) and dialysis access. The launch marks a significant milestone as Solaris aims to address critical gaps in vascular care, with a focus on high-quality, durable solutions to prevent restenosis and improve long-term vessel patency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERIPHERAL INTERVENTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Boston Scientific
  • Medtronic
  • Cook Medical
  • Cordis
  • Terumo Corporation
  • Johnson & Johnson
  • Teleflex
  • B. Braun Melsungen
  • Penumbra, Inc.
  • Endologix
  • Merit Medical Systems
  • Philips Healthcare
  • AngioDynamics
  • Siemens Healthineers
  • Others

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Catheters
  • Guidewires
  • Balloons
  • Vascular Closure Devices

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Stenting
  • Atherectomy
  • Thrombolysis

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peripheral Interventions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peripheral Interventions Market Snippet by Product Type
    • 2.1.2. Peripheral Interventions Market Snippet by Procedure
    • 2.1.3. Peripheral Interventions Market Snippet by End-Use
    • 2.1.4. Peripheral Interventions Market Snippet by Country
    • 2.1.5. Peripheral Interventions Market Snippet by Region
  • 2.2. Competitive Insights

3. Peripheral Interventions Key Market Trends

  • 3.1. Peripheral Interventions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peripheral Interventions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peripheral Interventions Market Opportunities
  • 3.4. Peripheral Interventions Market Future Trends

4. Peripheral Interventions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peripheral Interventions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Peripheral Interventions Market Landscape

  • 6.1. Peripheral Interventions Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peripheral Interventions Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Catheters
    • 7.1.4. Guidewires
    • 7.1.5. Balloons
    • 7.1.6. Vascular Closure Devices

8. Peripheral Interventions Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Stenting
    • 8.1.4. Atherectomy
    • 8.1.5. Thrombolysis

9. Peripheral Interventions Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Specialty Clinics

10. Peripheral Interventions Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Peripheral Interventions Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Peripheral Interventions Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Peripheral Interventions Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Peripheral Interventions Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Peripheral Interventions Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Peripheral Interventions Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Boston Scientific
    • 11.2.3. Medtronic
    • 11.2.4. Cook Medical
    • 11.2.5. Cordis
    • 11.2.6. Terumo Corporation
    • 11.2.7. Johnson & Johnson
    • 11.2.8. Teleflex
    • 11.2.9. B. Braun Melsungen
    • 11.2.10. Penumbra, Inc.
    • 11.2.11. Endologix
    • 11.2.12. Merit Medical Systems
    • 11.2.13. Philips Healthcare
    • 11.2.14. AngioDynamics
    • 11.2.15. Siemens Healthineers
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제